Comment & Analysis
Ian Cowie: patient capital review great news for trusts
The penny has dropped at the Treasury with the chancellor’s announcement that listed venture capital funds are a good way to finance new, growth companies.
My investment trust winners and losers from 2016/17
Peter Hewitt, investment trust picker for F&C Managed Portfolio, reveals the closed end funds that stood out in a turbulent but positive year.
ESO: the private equity fund lighting up an overlooked sector
Matthew Read of Marten & Co assesses the post-crisis record of EPE Special Opportunities.
John Spiers: what put us off popular PRS Reit
PRS real estate investment trust raised an impressive £250 million in May. EQ Investors' founder explains why wealth manager did not get involved.
Trust Tips: Winterflood prunes New Year recommendations
Winterflood Securities takes profits and makes some big calls on its investment trust recommendations in anticipation of a rougher time for stock markets.
Trust Tips: Numis' nine changes for cautious markets
Half-year review of investment trust recommendations sees Numis Securities' change two equity funds and seven in pricey 'alternative assets'.
Dividends and biotech: a blockbuster combination?
Anyone in doubt about the revitalising effect dividends can have on an investment trust’s share price need only look at International Biotechnology Trust.
James Carthew: a Reit long and winding road
A look at LXI real estate investment trust and the small band of real estate investment trusts focused on properties let on long leases.
Investment Trust Watch: tender frenzy shakes up shares
Shares in Invesco Asia are looking expensive after its board spent £39.2 million buying back a big chunk of them this morning.
James Carthew: the relentless rise of new income funds
Investors continue to pour money into new property, infrastructure and specialist equity investment companies.